Library / Skin / hair / Melanotan II

α-MSH analog · unregulated tanning peptide

Melanotan II

High-caution Not approved for tanning

ClassNon-selective melanocortin agonist
Sought effects in gray marketPigment, appetite, sexual
EvidenceOld clinical exploration; modern use is unregulated
Related approved cousinAfamelanotide / Scenesse is a different product

What it is

Melanotan II is a cyclic α-MSH analog that darkens melanin and also hits receptors involved in appetite and sexual function. It is not an approved tanning drug. Afamelanotide (Scenesse) is a different, tightly indicated medicine.

Benefits in plain language

What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.

If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.

Mechanism of action

MC1R drives eumelanin; other MC receptors explain nausea, blood-pressure, and sexual side effects. Pigment change includes existing moles.

Possible side effects / caveats

Nausea, flushing, appetite change, spontaneous erections, darkening of moles/freckles, new nevi reports, and blood-pressure effects. This is one of the worse risk/benefit stories in the gray-market peptide set.

Protocol ranges

Source tierAmountFrequency / durationNotes
Cited rangeVariable mcg titration talkUnstandardizedNo safe “tanning protocol” belongs on a referral site
Included for identification and risk context, not as a protocol to copy. Mole and cardiovascular issues are the reason this page stays short on numbers.